Syncona's Achilles says cancer treatment shows promise; seals buy

(marketscreener.com) Syncona Ltd on Thursday noted a promising safety profile for a cancer therapy concocted by one investee, and separately announced the completion of an acquisition in the retinal gene therapy space. Syncona said Achilles Therapeutics PLC will next week at an industry conference present clinical data evaluating its T-cell cancer therapy. Updated...https://www.marketscreener.com/quote/stock/SYNCONA-LIMITED-11814171/news/Syncona-s-Achilles-says-cancer-treatment-shows-promise-seals-buy-42450012/?utm_medium=RSS&utm_content=20221201